What is the scope and duration of Exzeo's repurchase program?

Exzeo's Board has authorized up to $25 million in stock repurchases effective immediately, with a one-year term. The program does not obligate the company to repurchase any minimum number of shares and may be suspended or terminated at management's discretion without notice.

How will Exzeo execute buybacks under this program?

The company may use open-market purchases under Rule 10b-18, Rule 10b5-1 trading plans, block transactions, or privately negotiated transactions. The timing and amount of repurchases depend on business conditions, market prices, liquidity, regulatory requirements, and other factors at management's discretion.

What is Rule 10b5-1 and why might Exzeo use it?

Rule 10b5-1 allows companies to establish pre-set trading plans for share repurchases that operate under a safe harbor from insider-trading liability. The plan is typically established during a non-trading blackout window and executes according to predetermined terms, reducing legal risk and providing transparency.

Will Exzeo disclose repurchase activity under this program?

Yes. Exzeo is required to report any share repurchases in its periodic filings on Forms 10-Q (quarterly) and 10-K (annual) with the SEC, consistent with Securities Exchange Act rules and SEC disclosure requirements.

Is Exzeo required to complete this $25 million program?

No. The authorization is entirely discretionary. Management can modify, suspend, or cancel the program at any time based on business performance, market conditions, share price, available cash, regulatory developments, or other considerations. There is no obligation to repurchase any specific amount or number of shares.

XZO 8-K Filed 2026-08-14 New authorization

Exzeo authorizes $25M stock repurchase program

Insurance-tech firm greenlights one-year buyback under Rule 10b-18 and 10b5-1 frameworks

Authorization$25M

MechanismRule 10b-18 open-market purcha

What the filing says

Exzeo Group Inc. (NYSE: XZO) announced on August 14, 2026, that its Board of Directors has authorized a program to repurchase up to $25 million of the company's common shares, subject to market conditions. The program does not obligate the company to acquire a specific number of shares and may be canceled or suspended at any time without notice.

The repurchase program authorizes Exzeo to purchase shares through open-market purchases, block transactions, privately negotiated transactions, or other means, including trading programs intended to qualify under Rule 10b5-1 under the Securities Exchange Act of 1934, and in accordance with Rule 10b-18. The timing and total amount of repurchases will be determined at management's discretion and depend upon business, economic and market conditions, corporate and regulatory requirements, prevailing stock prices, and other considerations.

The share repurchase program has a term of one year from authorization. Information regarding any share repurchases executed under the program will be disclosed in the company's future periodic reports on Forms 10-Q and 10-K filed with the SEC as required by applicable rules.

Exzeo Group Inc. (NYSE: XZO) today announced that its Board of Directors has authorized a program to purchase up to $25 million of the company's common shares, subject to market conditions. — Exzeo Group, Inc. 8-K filing · View on SEC EDGAR →

What this means

Exzeo has authorized a $25 million discretionary repurchase program effective through August 2027, with no minimum or maximum share-count obligations. The program allows management flexibility to repurchase shares using multiple mechanisms — open-market purchases under Rule 10b-18 and 10b5-1 trading plans — contingent on market, business, and regulatory conditions. As a non-obligatory authorization that can be suspended or terminated at any time, the actual financial impact will depend entirely on management's future capital allocation decisions and market execution. The filing does not disclose the company's current market capitalization, share count, or historical repurchase activity for comparative context.

Frequently asked questions

What is the scope and duration of Exzeo's repurchase program?: Exzeo's Board has authorized up to $25 million in stock repurchases effective immediately, with a one-year term. The program does not obligate the company to repurchase any minimum number of shares and may be suspended or terminated at management's discretion without notice.
How will Exzeo execute buybacks under this program?: The company may use open-market purchases under Rule 10b-18, Rule 10b5-1 trading plans, block transactions, or privately negotiated transactions. The timing and amount of repurchases depend on business conditions, market prices, liquidity, regulatory requirements, and other factors at management's discretion.
What is Rule 10b5-1 and why might Exzeo use it?: Rule 10b5-1 allows companies to establish pre-set trading plans for share repurchases that operate under a safe harbor from insider-trading liability. The plan is typically established during a non-trading blackout window and executes according to predetermined terms, reducing legal risk and providing transparency.
Will Exzeo disclose repurchase activity under this program?: Yes. Exzeo is required to report any share repurchases in its periodic filings on Forms 10-Q (quarterly) and 10-K (annual) with the SEC, consistent with Securities Exchange Act rules and SEC disclosure requirements.
Is Exzeo required to complete this $25 million program?: No. The authorization is entirely discretionary. Management can modify, suspend, or cancel the program at any time based on business performance, market conditions, share price, available cash, regulatory developments, or other considerations. There is no obligation to repurchase any specific amount or number of shares.

authorization rule-10b-18 10b5-1 insurance-tech one-year-term

Source. This editorial summary is based on the SEC filing linked above. BuybackStocks aggregates and editorializes publicly available SEC EDGAR filings. Not investment advice. Past authorization announcements do not guarantee future repurchase activity or share price performance. See our full disclosures policy.